Hans-Ludwig Weidenmuller

Title: The Innovations of Hans-Ludwig Weidenmuller

Introduction

Hans-Ludwig Weidenmuller is a notable inventor based in Hofheim am Taunus, Germany. He has made significant contributions to the field of biochemistry, particularly in the development of enzyme inhibitors. With a total of 3 patents to his name, Weidenmuller has focused on innovative solutions that address digestive health.

Latest Patents

Weidenmuller's latest patents include an alpha-amylase inhibitor derived from a streptomycete. This invention specifically targets glycoside hydrolases of the digestive tract, particularly pancreatic alpha-amylase. The process involves fermentation of the specific microorganism Streptomyces tendae, strain 4158, along with its variants and mutants. Additionally, the patents detail processes for the isolation and purification of the inhibitor.

Career Highlights

Hans-Ludwig Weidenmuller has had a distinguished career, working at Hoechst Aktiengesellschaft, a leading company in the pharmaceutical and chemical sectors. His work has contributed to advancements in enzyme inhibitors, which have important applications in medicine and health.

Collaborations

Throughout his career, Weidenmuller has collaborated with esteemed colleagues such as Volker Oeding and Werner Pfaff. These partnerships have fostered innovation and have been instrumental in the development of his patented technologies.

Conclusion

Hans-Ludwig Weidenmuller is a prominent figure in the field of biochemistry, with a focus on enzyme inhibitors that have significant implications for digestive health. His contributions through patents and collaborations highlight his commitment to innovation in science and technology.